XML 102 R92.htm IDEA: XBRL DOCUMENT v3.23.2
SEGMENT INFORMATION - Disaggregation of Revenue (Details) - USD ($)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Disaggregation of Revenue [Line Items]        
Revenues $ 2,167 $ 1,967 $ 4,111 $ 3,885
Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 946 878 1,769 1,712
Devices        
Disaggregation of Revenue [Line Items]        
Revenues 496 450 975 908
OTC        
Disaggregation of Revenue [Line Items]        
Revenues 461 401 855 777
Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 243 215 469 438
Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 21 23 43 50
Salix        
Disaggregation of Revenue [Line Items]        
Revenues 557 501 1,053 965
Salix | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 558 501 1,054 965
Salix | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Salix | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues (1) 0 (1) 0
International        
Disaggregation of Revenue [Line Items]        
Revenues 259 233 506 477
International | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 60 67 117 125
International | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
International | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 39 34 78 72
International | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 148 122 286 255
International | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 12 10 25 25
Solta Medical        
Disaggregation of Revenue [Line Items]        
Revenues 88 57 161 129
Solta Medical | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Solta Medical | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 88 57 161 129
Solta Medical | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Solta Medical | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Solta Medical | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Diversified        
Disaggregation of Revenue [Line Items]        
Revenues 228 235 425 484
Diversified | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 194 196 356 401
Diversified | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 0 0 0 0
Diversified | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 1 1 3 3
Diversified | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 27 31 54 67
Diversified | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues 6 7 12 13
Bausch + Lomb        
Disaggregation of Revenue [Line Items]        
Revenues 1,035 941 1,966 1,830
Bausch + Lomb | Pharmaceuticals        
Disaggregation of Revenue [Line Items]        
Revenues 134 114 242 221
Bausch + Lomb | Devices        
Disaggregation of Revenue [Line Items]        
Revenues 408 393 814 779
Bausch + Lomb | OTC        
Disaggregation of Revenue [Line Items]        
Revenues 421 366 774 702
Bausch + Lomb | Branded and Other Generics        
Disaggregation of Revenue [Line Items]        
Revenues 68 62 129 116
Bausch + Lomb | Other revenues        
Disaggregation of Revenue [Line Items]        
Revenues $ 4 $ 6 $ 7 $ 12